ENTX
Entera Bio Ltd
2.90$
-1.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +37.4% | -13.0% | -2.0% | -22.9% | +21.3% | +130.0% | -8.9% | -11.5% | -8.1% | -17.9% | +48.4% | |
| – | +40.4% | -13.4% | -1.6% | -23.5% | +22.2% | +136.5% | -9.0% | -11.9% | -58.2% | +75.8% | +51.3% | |
| – | +45.3% | -16.0% | -1.4% | -24.3% | +25.2% | +45.2% | -13.6% | -21.0% | -17.1% | -41.8% | +173.4% | |
| – | +45.3% | -16.0% | -1.4% | -24.3% | +25.2% | +45.2% | -13.6% | -21.0% | -17.1% | -41.8% | +173.4% | |
| – | – | – | +82.6% | -66.7% | +200.0% | +0.0% | -100.0% | – | – | – | – | |
| – | -40.8% | -0.2% | +9.2% | -14.2% | +1.6% | +69.5% | +8.6% | -9.9% | +33.1% | -15.6% | +400.2% | |
| – | -46.2% | +2.7% | +15.4% | -14.1% | +5.9% | +38.0% | +13.6% | -14.8% | +40.2% | -28.5% | +33.5% | |
| – | +2.3% | +14.2% | +1.3% | +4.5% | +4.9% | -0.6% | +14.8% | -12.4% | +35.3% | -19.6% | +7.6% | |
| – | -85.3% | -20.5% | +4.5% | +166.7% | -28.3% | +1.5% | +185.8% | -43.6% | +107.4% | -38.8% | +109.9% | |
| – | +66.5% | -14.7% | -3.7% | -24.4% | +25.2% | +139.8% | -11.0% | -11.7% | -14.0% | -18.4% | -32.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3.1% | +23.7% | +1.0% | +1.5% | +0.0% | +15.2% | +8.0% | +0.5% | -1.9% | +3.4% | +5.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.